Cover Image
Market Research Report

Blood Banking and Blood Products

Published by Global Industry Analysts, Inc. Product code 136179
Published Content info 553 Pages
Delivery time: 1-2 business days
Price
Back to Top
Blood Banking and Blood Products
Published: October 1, 2015 Content info: 553 Pages
Description

This report analyzes the worldwide markets for Blood Banking and Blood Products in US$ Million by the following Product Group/Types: Blood Components and Plasma Products (Whole Blood & Cellular Components; and Plasma Fractions), and Equipment, Blood Tests and Other Consumables. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 235 companies including many key and niche players such as -

AABB
Americas Blood Centers
American Red Cross
Canadian Blood Services
Japan Red Cross Society

Table of Contents
Product Code: MCP-1028

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study
    • Blood Components and Plasma Products
      • Whole Blood & Cellular Components
        • WBCs
        • RBCs
        • Platelets
      • Plasma Fractions
        • Fresh Frozen Plasma
        • Albumin Fractions
        • Factor VIII
        • Factor IX and Factor IX Complex
        • Fibrin/Thrombin
    • Equipment, Blood Tests and Consumables
      • Automated Analyzers for Blood Analysis
      • Blood Test Consumables

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Prelude
  • Blood Transfusion Worldwide: A Kaleidoscope of Stark Contrasts
  • Safety and Availability: The Core Issues
    • Table 1: Prevalence of Major Transfusion-transmitted Infections by Economic Group (H2 2014): Percentage of HIV, HBV and HCV in High Income, Middle-income and Low Income Countries (includes corresponding Graph/Chart)
  • Current and Future Analysis
  • Analysis of World Blood Banking & Blood Products by Value Sales
    • Analysis by Geographic Region
    • Analysis by Product Group/Type
      • Plasma and Plasma Derivatives Continue to Dominate Blood Components Market
    • Table 2: Global Plasma Derivatives Market by Product (2015E & 2017P): Percentage Breakdown of Consumption Value for Albumin, Alpha-1, FVIII, IVIg, and Others (includes corresponding Graph/Chart)
      • Equipment, Blood Tests & Other Consumables to Display Steady Growth
  • World Blood Components and Plasma Market Analysis
    • Table 3: World Recent Past, Current & Future Analysis for Blood Components and Plasma by Region/Country - US, Europe, Japan, and Rest of World Markets Independently Analyzed with Annual Consumption in Million Units for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 4: World 7-Year Perspective for Blood Components and Plasma by Region/ Country - Percentage Breakdown of Volume Consumption for US, Europe, Japan, and Rest of World Markets for Years 2014, 2015 & 2020 (includes corresponding Graph/Chart)
  • Red Blood Cells - A Key Blood Component
    • Table 5: World Recent Past, Current & Future Analysis for Red Blood Cells by Region/ Country - US, Europe, Japan, and Rest of World Markets Independently Analyzed with Annual Consumption in Million Units for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 6: World 7-Year Perspective for Red Blood Cells by Region/Country - Percentage Breakdown of Volume Consumption for US, Europe, Japan, and Rest of World Markets for Years 2014, 2015 & 2020 (includes corresponding Graph/Chart)

2. MARKET TRENDS & ISSUES

  • Blood Plasma Demand Exceeds Supply: Self-Sufficiency is the New Mantra
  • Manufacturers Step Up Production Capacity to Meet Growing Demand for Plasma Derivative Products
  • Platelet Rich Plasma Therapy Market Scales New Heights
  • Increasing Awareness of PID and CIPD Disorders to Drive IVIg Market
    • Indications Addressed by Major Global IVIg Manufacturers
    • Table 7: Comparative Costs between Plasma Protein Therapies and Artificially Synthesized Pharmaceuticals (includes corresponding Graph/Chart)
  • Growing Affinity for Home Care Unlocks Opportunities for Home-based IVIg Therapy
    • Table 8: Worldwide Home Healthcare Services Market by Type of Service (2015E & 2020P): Percentage Breakdown of Service Revenues for Infusion Therapy Services, Rehabilitation Services, Respiratory Therapy Services, Telemetry, and Unskilled Homecare (includes corresponding Graph/Chart)
  • Unsuccessful Clinical Trials for Alzheimer's a major Setback for IVIg Market
  • Huge Under-Diagnosed Pool of AAT Patients Highlights High Potential for Alpha-1 Protein
  • Rising Incidence of Cancer Drives Demand for Apheresis Systems
  • PrIME: An Innovative High-Yield Process to Address Supply Dearth
  • Present State of Plasma Fractionating Industry
  • Plasma Fractionation Industry Concentrated in Developed Countries
  • PrIME Tackles the Issue of Currently Unprocessable Plasma
  • Industry Grappling with Blood Safety & Availability Issues
  • New Infections - A Continuous Threat
  • Synthetic Substitutes to Bridge Demand-Supply Gap in Blood
  • Autologous Transfusion Gearing up for High Growth
  • Out-of-Hospital Transfusions: An Emerging Phenomenon
  • Automation Tapping into Blood Market
  • Automated in Pre-Transfusion Diagnostics
  • Penetration of Automated Equipment in the Plasma Market
  • The Red Blood Cell Collection Opportunity
  • Robots in Blood Banking
    • Blood Banks Switching from Manual to Automated Cooler Validation
  • Automated Blood Processing Systems in Open Heart Surgeries
  • Automated Systems in Cancer
  • Pooling: Economical HIV Testing
  • Ballooning Global Geriatric Populace to Drive Demand for Blood Products`
    • Table 9: Elderly Population (65+ Years) as a Percentage of the Total Population: 2014 & 2025 (includes corresponding Graph/Chart)
    • Table 10: Life Expectancy at Age 60 and 80 Years - (2010-2015), (2020-2025) & (2045-2050) (includes corresponding Graph/Chart)
  • Improving Healthcare Expenditure to Foster Growth of Blood Banking Sector
    • Table 11: Global Intravenous Immunoglobulin Consumption in Kilograms per Million Residents for Select Countries (includes corresponding Graph/Chart)
    • Table 12: Per-Capita Healthcare Expenditure in US$ for Select Regions (2014) (includes corresponding Graph/Chart)

3. COMPETITIVE LANDSCAPE

  • Leaders in Global Blood Plasma Ramp Up Market Share
    • Table 13: Global Plasma Fractionation Capacity by Leading Producers (2016 & 2020): Percentage Breakdown of Production Capacity for Baxter, Biotest, CSL, Grifols, Kedrion, Octapharma, and Others (includes corresponding Graph/Chart)
  • IVIg - A Highly Consolidated Market
    • Table 14: Global Market for Immunoglobulin (IVIg and SCIg) by Leading Players (2014): Percentage Breakdown of Value Sales for Baxter, CSL, Grifols, Kedrion, Octapharma, and Others (includes corresponding Graph/Chart)
    • Table 15: Global IVIg Market by Leading Players (2014): Percentage Breakdown of Value Sales for Baxter, CSL, Grifols, Kedrion, Octapharma, and Others (includes corresponding Graph/Chart)
    • Select IVIg Products Offered by Global Leading Players
    • Table 16: Global Subcutaneous Immunoglobulin Market by Leading Player (2014): Percentage Market Share Breakdown of Revenue for Baxter, CSL, and Grifols (includes corresponding Graph/Chart)
  • Big Three Corner Majority of Blood Collection Systems Market
    • Table 17: Global Whole Blood Collection Systems Market (2015E): Percentage Breakdown of Value Sales for Fresenius/Fenwal, Haemonetics, MacoPharma, Terumo, WEGO, and Others (includes corresponding Graph/Chart)
    • Table 18: Global Apheresis Systems Market (2015E): Percentage Breakdown of Value Sales for Fresenius/Fenwal, Haemonetics, Terumo, and Others (includes corresponding Graph/Chart)
  • Key Statistics
    • Table 19: Global Human Albumin Market by Leading Players (2014): Percentage Breakdown of Value Sales for Baxter, CSL, Grifols, Octapharma, and Others (includes corresponding Graph/Chart)
    • Table 20: Global Plasma-Derived Factor VIII Market by Leading Players (2014): Percentage Breakdown of Value Sales for Baxter, Biotest, CSL, Grifols, Kedrion, Octapharma, and Others (includes corresponding Graph/Chart)
    • Table 21: Global Alpha-1 Market by Leading Players (2014): Percentage Breakdown of Value Sales for Baxter, CSL, Grifols, and Others (includes corresponding Graph/Chart)
    • Table 22: Global In-Vitro Diagnostics Instruments, Reagents & Supplies Market by Leading Players (2015E): Percentage Breakdown of Value Sales for Abbott, bioMerieux, Danaher, Johnson & Johnson, Roche, Siemens, and Others (includes corresponding Graph/Chart)
    • Table 23: Global Molecular Diagnostics Instruments, Reagents & Supplies Market by Leading Players (2015E): Percentage Breakdown of Value Sales for Abbott, Becton Dickinson, Gen-Probe/Hologic, Novartis, Qiagen, Roche, and Others (includes corresponding Graph/Chart)

4. PRODUCT OVERVIEW

  • Blood Banking and Blood Products Industry
  • Blood Components and Plasma Products
  • Equipment, Blood Tests and Consumables
    • Automated Analyzers for Blood Analysis
    • Blood Tests
    • Consumables
      • Blood Collection Equipment
      • Blood Collection Monitors
      • Blood Donor Couches
      • Blood Processing Equipment
      • Blood Bank Centrifuges
      • Plasma Thawing
      • Blood Cell Separators
      • Blood Storage Equipment
      • Blood Bags
      • Platelet Agitators
      • Blood Bank Refrigerators
  • Blood - A Primer
  • Ionic Structure
    • Blood Components and their Applications
  • Blood Constituents
  • Plasma
  • Red Blood Cells (RBC)
    • Blood Count
  • Platelets
  • White Blood Cells (WBC)
  • Derivative Products of Blood or Plasma Fractions
  • Albumin Fractions
  • Immunoglobulins
  • Hyper-Immune Immunoglobulin
  • Factor VIII
  • Factor IX and Factor IX Complex
  • Fibrin/Thrombin
    • Consumption of Blood Based on Type of Surgery/Accident (In Units)
    • Table 24: Worldwide Market for Plasma Derivative Products by Product Type (2014): Percentage Breakdown of Revenue Sales for A1PI, Albumin, Coagulation Factor, Hyperimmunes, IVIG, Plasma Derived Factor VIII, Prothrombin Complex Concentrate, and Others (includes corresponding Graph/Chart)
  • Recombinant Products
    • Development Pipeline of Select rFVIII Products Developed for Hemophilia Therapy
  • Blood Plasma Sourcing
    • Table 25: Global Plasma Derivatives Market: Percentage Breakdown of Costs Associated with Production (includes corresponding Graph/Chart)
  • Plasma Protein and Fractionation
    • Plasma Fractionation: Origins and Development
    • Table 26: Plasma Fractionation Processes: Comparison of Cohn IVIG and PrIME IVIG Based on Specific Characteristics
    • The Need
    • Fresh Frozen Plasma
    • Other Plasma Fractions
      • IVIG
      • Factor VIII
      • Albumin
  • Therapeutic Uses of Plasma Products
  • Albumin Products
  • Immunoglobulins
    • Intravenous Immunoglobulin (IVIg)
    • Normal Immunoglobulin (IMIg)
    • CMV Immunoglobulin
    • Hepatitis B Immunoglobulin
    • Rh (D) Immunoglobulin
    • Tetanus Immunoglobulin IM
    • Zoster Immunoglobulin
  • Plasma Derived Coagulant Products
    • Biostate(r)
    • Ceprotin(r)
    • Factor VII Concentrate
    • Factor XI Concentrates
    • Feiba VH(r) Inhibitor Treatment
    • Fibrogammin P(r)
    • Monofix(r)-VF
    • ProthrombinexTM-HT
    • Thrombotrol(r)-VF

5. BLOOD COLLECTION METHODS

  • Banking the Natural Blood Resources
  • Blood Banks
  • Blood Banking
  • Blood Transfusion
  • Role of Blood Banks
  • Blood Donor: The Epicenter of the Process
  • Eligibility Criteria for the Donor
  • The Basics of Blood Donation - Myths & Facts
    • Table 27: Active Donors of Whole Blood and Apheresis per 1,000 of Population by Country/ Agency (includes corresponding Graph/Chart)
    • Table 28: Percentage Breakdown of Apheresis and Whole Blood Donations by Country (includes corresponding Graph/Chart)
  • Collection Methods
  • Blood Donation: The Process
    • Types of Blood Donation
      • Directed Blood Donations
      • Autologous Blood Donation
      • Alternative Usage of Patient's Own Blood
      • General Blood Donation
      • Hemodilution
      • Wound Drainage
      • Cell Saver
    • The Method
  • Blood Salvaging
  • Blood Collection Centers
    • Blood Collection Management System
      • A Historical Retrospective
      • Blood Collection Centers
    • Types of Blood Collection Centers
      • Cord Blood Banks
      • Profit Collection Centers
      • Military Blood Banks
      • Hospital Blood Banks
      • Community Blood Banks
      • Non-Profit Collection Centers
  • Blood Processing
    • Blood Typing
      • Rh Blood Group System
      • ABO Blood Group System
      • Blood Types and their Compatibility
    • Table 29: Occurrence of Blood Groups Worldwide (In %) (includes corresponding Graph/Chart)
    • Blood Test
    • Blood Culture
  • The Costs
  • History of Blood Banking

6. THE DYNAMIC LANDSCAPE OF TRANSFUSION TECHNOLOGIES & TESTS

  • Blood Transfusion: A Backdrop
  • Massive Transfusion
  • Complications and Risks Due to Transfusion
  • Circulatory Overload
  • Graft Versus Host Disease (GVHD)
  • Hemolytic Transfusion Reactions
  • Iron Overload
  • Bacterial Contamination
  • Thrombophlebitis
  • Allergic Reactions
  • Air Embolism
  • Hyperkalaemia
  • Changing Role of Blood Banking Technology

7. BLOOD TRANSFUSION: THE PROCESS, TESTS/TECHNOLOGIES

  • Cross Matching
  • Blood Donor/Recipient Screening
  • Blood Typing
  • Leukoreduction
  • Leukocyte Reduction Specification Standards/Filters
  • Coombs Test

8. ALTERNATIVES TO BLOOD TRANSFUSION: A REAL THREAT TO THE INDUSTRY

  • Bloodless Surgery
  • Therapeutic Apheresis
  • Plasmapheresis
  • Plateletpheresis
  • Leukapheresis
  • Volume Expanders
  • Colloids
    • Albumin
    • Dextrans
    • Hydroxyethyl Starch
  • Crystalloids
  • Blood Growth Factor Therapies - Newer Alternatives to Transfusion

9. RECENT INDUSTRY ACTIVITY

  • OneBlood to Merge with The Blood Alliance
  • Cerus Corporation Inks Purchase Agreement with Karolinska University Hospital
  • Cerus Corporation Signs Purchase Agreement with Blood Bank of Delmarva
  • Canadian Blood Services Closes 3 Permanent Clinics, Terminates Bloodmobile Program
  • Roche Releases Elecsys HTLV-I/II Immunoassay
  • Roche Receives USFDA Approval for cobas TaqScreen MPX Test v2.0 for HIV, HCV, and HBV Tests
  • China Biologic Products Purchases Additional Stake in Guizhou Taibang Biological Products
  • Community Blood Center Merges with New York Blood Center
  • Cerus Corp. Partners with Kawasumi Laboratories for Developing Intercept Platelets Kits
  • Vascular Solutions Collaborates with US AMMDA to Develop Plasma Products for Treating Hemorrhage
  • The San Diego Blood Bank Collaborates with Clinical and Translational Research Institute
  • Affinity Biologicals Unveils Factor VIII Deficient, Factor IX Deficient Plasmas
  • AABB Collaborates with AATM for Promoting Blood and Cellular Therapies Standards in Asia
  • bioCSL Partners with Immucor for Distributing Transfusion Technology in Australia and New Zealand
  • PrIME Biologics Opens Plasma Fractionation Plant in Singapore
  • Terumo BCT Acquires Medservice
  • Grifols Acquires Transfusion Diagnostics Unit of Novartis
  • Lab21 Divests Blood Bank Screening, Molecular Assets to Trinity Biotech
  • New York Blood Center Acquires Coral Blood Services
  • Entegrion Inks Licensing Agreement with Kedrion Melville for Developing Resusix
  • Davao del Norte Opens New Blood Banking Facility

10. FOCUS ON SELECT GLOBAL PLAYERS

  • Leading Blood Banks
  • AABB (USA)
  • America's Blood Centers (USA)
  • American Red Cross (USA)
  • Canadian Blood Services (Canada)
  • Japan Red Cross Society (Japan)
  • New York Blood Center (USA)
  • Sanquin Blood Supply Foundation (The Netherlands)
  • Leading Players in Blood Bank Technology and Supplies
  • Abbott Diagnostics, Inc. (USA)
  • Beckman Coulter, Inc. (USA)
  • Becton, Dickinson and Company (USA)
  • bioMerieux SA (France)
  • Bio-Rad Laboratories, Inc. (USA)
  • Cerus Corporation (USA)
  • CSL Behring LLC (USA)
  • Fresenius Kabi AG (Germany)
    • Fenwal Inc. (USA)
  • Gen-Probe, Inc. (USA)
  • Haemonetics Corporation (USA)
  • Immucor Inc. (USA)
  • Kawasumi Laboratories, Inc. (Japan)
  • MacoPharma SA (France)
  • Ortho-Clinical Diagnostics, Inc. (USA)
  • Terumo BCT Inc. (USA)
  • Leading Players in Plasma Fractionation
  • Baxter International Inc. (USA)
  • Beijing Tiantan Biological Products Co., Ltd (China)
  • Bharat Serums and Vaccines Ltd (India)
  • Bio Products Laboratory Ltd (UK)
  • Biotest AG (Germany)
  • China Biologic Products, Inc. (China)
  • Grifols S.A. (Spain)
  • Huanlan Biological Engineering Inc. (China)
  • Kedrion S.p.A. (Italy)
  • LFB Group (France)
  • Octapharma AG (Switzerland)
  • OMRIX Biopharmaceuticals Ltd (Israel)
  • Shanghai RAAS Blood Products Co., Ltd. (China)
  • Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. (China)

11. GLOBAL MARKET PERSPECTIVE

    • Table 30: World Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 31: World Historic Review for Blood Banking and Blood Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 32: World 14-Year Perspective for Blood Banking and Blood Products by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
  • Blood Banking and Blood Products Market by Product Group/Type
    • Table 33: World Recent Past, Current & Future Analysis for Blood Components and Plasma Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 34: World Historic Review for Blood Components and Plasma Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 35: World 14-Year Perspective for Blood Components and Plasma Products by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 36: World Recent Past, Current & Future Analysis for Blood Components and Plasma Products by Product Type - Whole Blood & Cellular Components, and Plasma Fractions Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 37: World Historic Review for Blood Components and Plasma Products by Product Type - Whole Blood & Cellular Components, and Plasma Fractions Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 38: World 14-Year Perspective for Blood Components and Plasma Products by Product Type - Percentage Breakdown of Value Sales for Whole Blood & Cellular Components, and Plasma Fractions Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 39: World Recent Past, Current & Future Analysis for Whole Blood & Cellular Components by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 40: World Historic Review for Whole Blood & Cellular Components by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 41: World 14-Year Perspective for Whole Blood & Cellular Components by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 42: World Recent Past, Current & Future Analysis for Plasma Fractions by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 43: World Historic Review for Plasma Fractions by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 44: World 14-Year Perspective for Plasma Fractions by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 45: World Recent Past, Current & Future Analysis for Equipment, Blood Tests and Other Consumables by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 46: World Historic Review for Equipment, Blood Tests and Other Consumables by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 47: World 14-Year Perspective for Equipment, Blood Tests and Other Consumables by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Current and Future Analysis
    • Demand for Blood Transfusion Continues to Wane
    • Table 48: US Blood and Organ Banks by Leading Players (2014): Percentage Share Breakdown of Revenues for American Red Cross, Baxter International Inc., Blood Systems, Musculoskeletal Transplant Foundation, New York Blood Center, and Others (includes corresponding Graph/Chart)
    • Table 49: US Blood Banking Market by Leading Suppliers (2015): Percentage Breakdown of Unit Volumes for American Red Cross, Blood Centers of America, and Others (includes corresponding Graph/Chart)
    • Table 50: American Red Cross Dominates US Blood Platelet Production (2014): Percentage Share Breakdown of Production Volume for American Red Cross, and Others (includes corresponding Graph/Chart)
    • Aging Baby-Boomer Demography: A Key Market Driver
    • Table 51: North American Elderly Population by Age Group: 1975-2050 (includes corresponding Graph/Chart)
    • Favorable Reimbursement and High Usage Make US the Largest Consumer of Immunoglobulins Worldwide
      • Recession Impacts Blood Bank Reserves
      • US Blood Collection & Supply Profile
      • Blood Group Distribution
    • Table 52: US Market for Blood Banking and Blood Products: Percentage Breakup of Blood Group by Rh Factor (includes corresponding Graph/Chart)
    • Table 53: Percentage Breakup of Rh Blood Types in the US by Racial Group (includes corresponding Graph/Chart)
    • US Plasma Industry Remains Highly Concentrated
    • Table 54: US Plasma Derivatives Market by Leading Suppliers (2015): Percentage Breakdown of Value Sales for Baxter, CSL, Grifols, and Others (includes corresponding Graph/Chart)
    • Table 55: US Immunoglobulin Market by Leading Players (2014): Percentage Breakdown of Volume Sales for Baxter Healthcare, CSL Ltd., Grifols, and Others (includes corresponding Graph/Chart)
    • Table 56: US Market for Intravenous Immunoglobulin by Leading Player (2014): Percentage Market Share Breakdown of Volume Sales for Baxter, CSL Behring, Grifols, Kedrion, Octapharma, and Others (includes corresponding Graph/Chart)
    • Table 57: US Market for Immunoglobulin by Leading Players (2014): Percentage Breakdown of Value Sales for Gammagard Liquid/Kiovig, Flebogamma/Gamunex, Privigen/Carimune NF, Octagam and Others (includes corresponding Graph/Chart)
    • Table 58: US Market for IVIg Products by Indication (2014 & 2020P): Percentage Breakdown of Volume Sales for CIDP, CLL, ITP, MMN, PID, and Other Neurological Diseases (includes corresponding Graph/Chart)
    • Table 59: US Specific Immunoglobulin Market by Product Type (2014): Percentage Breakdown of Value Sales for Anti-D, Anti-HB, Anti-T, and Rabies Immunoglobulin (includes corresponding Graph/Chart)
    • Table 60: US Specific Immunoglobulin Market by Leading Players (2014): Percentage Breakdown of Value Sales for Biotest, Cangene, CSL, Grifols, Kedrion, Sanofi (includes corresponding Graph/Chart)
    • Changing Supply Dynamics Alters Economics of Plasma Production
    • Table 61: Average Price per Gram of IVIg for Europe and US Markets (includes corresponding Graph/Chart)
    • Regulations Control Plasma Collection Industry
    • Key Statistics
    • Table 62: US Blood Bag (With Filters) Market (2014): Percentage Share Breakdown of Value Sales for Leading Companies - Fresenius/Fenwal, Haemonetics, Terumo, and Others (includes corresponding Graph/Chart)
    • Table 63: US Whole Blood Collection Market (2014): Percentage Share Breakdown of Volume Sales for Leading Companies - Fresenius/Fenwal, Haemonetics, Terumo and Others (includes corresponding Graph/Chart)
    • Table 64: US Automated Blood Collection Market (2014): Percentage Share Breakdown of Volume Sales for Leading Companies - Fresenius/ Fenwal, Haemonetics, and Terumo (includes corresponding Graph/Chart)
    • Strategic Corporate Activity
    • Select Key Players
  • B. Market Analytics
    • US Blood Components and Plasma Market Analyzed by Value Sales
    • Table 65: US Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 66: US Historic Review for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 67: US 14-Year Perspective for Blood Banking and Blood Products by Product Group/ Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • US Blood Components and Plasma Market Analyzed by Consumption in Units
    • Table 68: US Recent Past, Current & Future Analysis for Blood Components and Plasma by Blood Components- Red Blood Cells (RBCs), Platelets, and Fresh Frozen Plasma Markets Independently Analyzed with Annual Consumption in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 69: US Historic Review for Blood Components and Plasma by Blood Components - Red Blood Cells (RBCs), Platelets, and Fresh Frozen Plasma Markets Independently Analyzed with Annual Consumption in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 70: US 14-Year Perspective for Blood Components and Plasma by Blood Components - Percentage Breakdown of Volume Consumption for Red Blood Cells (RBCs), Platelets, and Fresh Frozen Plasma for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Current and Future Analysis
    • Bleeding Disorders - A Major Threat
    • 'CSA-Z902-04' - A Comprehensive Voluntary Blood Safety Standard
    • Strategic Corporate Developments
    • Canadian Blood Services - The Major Blood Bank
  • B. Market Analytics
    • Table 71: Canadian Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 72: Canadian Historic Review for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 73: Canadian 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

3. JAPAN

  • A. Market Analysis
    • Current and Future Analysis
    • Japan Witnesses Surge in Imported Blood Products
    • Growing Market for Fresh Frozen Plasma
    • Growing Use of Imported Albumin Based Blood Products
    • The Goal of Self-Sufficiency
    • Graying Population to Drive Market Growth
    • Table 74: Japanese Elderly (65+ Years) Population for the Period 2000-2020 (includes corresponding Graph/Chart)
    • Corporate Development
    • Select Players
  • B. Market Analytics
    • Table 75: Japanese Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 76: Japanese Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 77: Japanese 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Current and Future Analysis
    • Market Trends and Issues
      • Legislations on Payment for Donation Restrict Donors
      • Government's Check on Healthcare Costs Pressurizes BCT Manufacturers
      • Purchasing System Witnesses Modifications
    • Aging Population to Drive Demand for IVIg Products
    • Table 78: Aging Population in Europe by Geographic Region (2015E & 2020): Percentage of Elderly Individuals of Age 60 Years and Above Compared to Overall Population for Eastern Europe, Northern Europe, Southern Europe, and Western Europe (includes corresponding Graph/Chart)
    • Table 79: European Market for Intravenous Immunoglobulin by Leading Player (2014): Percentage Market Share Breakdown of Volume Sales by Plasma Fractionators for Baxter Healthcare, Biotest, CSL Behring, Grifols, Kedrion, Octapharma, and Others (includes corresponding Graph/Chart)
    • Overview of Blood Banking Market
    • Table 80: European Blood Bag Market (2014E): Percentage Breakdown of Value Sales for Leading Companies - Fresenius/Fenwal, MacoPharma, Terumo and Others (includes corresponding Graph/Chart)
    • Table 81: European Whole Blood Collection Market (2014): Percentage Share Breakdown of Volume Sales for Leading Companies - Fresenius/Fenwal, MacoPharma, Terumo, and Others (includes corresponding Graph/Chart)
    • Table 82: European Automated Blood Collection Market (2014): Percentage Share Breakdown of Volume Sales for Leading Companies - Fresenius/Fenwal, Haemonetics, Terumo, and Others (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 83: European Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 84: European Historic Review for Blood Banking and Blood Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 85: European 14-Year Perspective for Blood Banking and Blood Products by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 86: European Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 87: European Historic Review for Blood Banking and Blood Products by Product Group/ Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 88: European 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4a. FRANCE

  • A. Market Analysis
    • Current and Future Analysis
    • Key Players
  • B. Market Analytics
    • Table 89: French Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 90: French Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 91: French 14-Year Perspective for Blood Banking and Blood Products by Product Group/ Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4b. GERMANY

  • A. Market Analysis
    • Current and Future Analysis
    • Select Players
  • B. Market Analytics
    • Table 92: German Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 93: German Historic Review for Blood Banking and Blood Products by Product Group/ Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 94: German 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4c. ITALY

  • A. Market Analysis
    • Current and Future Analysis
    • Kedrion S.P.A. - A Leading Italian Player for Plasma Fractionation
  • B. Market Analytics
    • Table 95: Italian Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 96: Italian Historic Review for Blood Banking and Blood Products by Product Group/ Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 97: Italian 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • A. Market Analysis
    • Current and Future Analysis
    • Bio Products Laboratory Ltd - A Leading UK Player for Plasma Fractionation
  • B. Market Analytics
    • Table 98: UK Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 99: UK Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 100: UK 14-Year Perspective for Blood Banking and Blood Products by Product Group/ Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4e. SPAIN

  • A. Market Analysis
    • Current and Future Analysis
    • Grifols, S.A - A Leading Spanish Player for Plasma Fractionation
  • B. Market Analytics
    • Table 101: Spanish Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 102: Spanish Historic Review for Blood Banking and Blood Products by Product Group/ Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 103: Spanish 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4f. RUSSIA

  • Market Analysis
    • Table 104: Russian Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020(includes corresponding Graph/Chart)
    • Table 105: Russian Historic Review for Blood Banking and Blood Products by Product Group/ Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 106: Russian 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4g. REST OF EUROPE

  • A. Market Analysis
    • Current and Future Analysis
    • Denmark - High Participation and Consumption of Blood
    • Strategic Corporate Developments
    • Select Players
  • B. Market Analytics
    • Table 107: Rest of Europe Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 108: Rest of Europe Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 109: Rest of Europe 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Current and Future Analysis
    • Table 110: Asia-Pacific Whole Blood Collection Market (2014E): Percentage Share Breakdown of Volume Sales for Leading Companies - Fresenius/Fenwal, Haemonetics, Weigao, and Others (includes corresponding Graph/Chart)
    • Table 111: Asia-Pacific Automated Blood Collection Market (2014E): Percentage Share Breakdown of Volume Sales for Leading Companies - Fresenius/Fenwal, Haemonetics, Terumo and Others (includes corresponding Graph/Chart)
    • ASEAN - Striding Towards Standardization of Blood Supply
  • B. Market Analytics
    • Table 112: Asia-Pacific Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Geographic Region - China, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 113: Asia-Pacific Historic Review for Blood Banking and Blood Products by Geographic Region - China, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 114: Asia-Pacific 14-Year Perspective for Blood Banking and Blood Products by Geographic Region - Percentage Breakdown of Value Sales for China, and Rest of Asia-Pacific Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 115: Asia-Pacific Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 116: Asia-Pacific Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 117: Asia-Pacific 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

5a. CHINA

  • A. Market Analysis
    • A Key Market
    • Government Wakes Up to Realities
    • Table 118: Chinese Market for Blood Banking and Blood Products: Percentage Breakdown of Blood Group by Type - A, B, O, and AB (includes corresponding Graph/Chart)
    • Table 119: Chinese Market for Blood Banking and Blood Products: Percentage Breakdown of Blood Donor by Gender - Male and Female (includes corresponding Graph/Chart)
    • Table 120: Chinese Blood Banking and Blood Products Market: Percentage Breakdown of Blood Donor by Age Group - 16-20, 21-30, 31-40, 41-50, 51-60, and 61-70 (includes corresponding Graph/Chart)
    • Overview of Chinese Blood Plasma Market
    • Table 121: Chinese Blood Products Demand by Type of Product (2014): Percentage Breakdown of Lot Release Volumes for Human IVIG, Human Albumin, Human Rabies Ig, Human Tetanus Ig, and Others (includes corresponding Graph/Chart)
      • Availability of Plasma Proteins in the US and China (2015): A Comparison
    • Table 122: Chinese Plasma Based Products Market by Product Type (2015 & 2020P): Percentage Breakdown of Value Sales for Human Albumin, Human IVIg, and Others (includes corresponding Graph/Chart)
    • Government Exercises Strict Control Over Production, Supply and Import of Plasma- based Products
    • Gap in Domestic Demand and Supply of Plasma Products Persists Despite Increasing Output
    • Table 123: Plasma Supply, Demand, and Deficit in Chinese Market: 2008-2014 (includes corresponding Graph/Chart)
    • Table 124: Rising Number of Plasma Collection Stations and Volume of Plasma Collection in China: 2018-2014 (includes corresponding Graph/Chart)
      • Comparison of Average Yields for Select Plasma Based Products in China and International Markets
    • Deregulation and Supply Crunch to Drive Up Retail Prices of Plasma-based Products
    • Expanding Medical Indications Holds Key to Boosting Market Growth
      • Comparison of USFDA and CFDA Approved Indications for Human Albumin Therapeutic Products
      • Comparison of USFDA and CFDA Approved Indications for Human IVIG Therapeutic Products
    • Competitive Landscape
    • Table 125: Chinese Plasma Collection Stations Market by Leading Players (2014): Percentage Breakdown of Stations Owned by China Biologic (CBPO), CNBG Shanghai Institute, Hualan Biological, Shanghai RAAS, and Others (includes corresponding Graph/Chart)
      • Blood Plasma Product Portfolio of Major Domestic Players
    • Table 126: Chinese Plasma Collection Market by Leading Players (2014): Percentage Volume Breakdown of Plasma Collection for Anhui Tonglu, CBPO, Chengdu Rongsheng, Hualan Biological, Shanxi Kangbao, Sichuan Shuyang, and Others (includes corresponding Graph/Chart)
    • Albumin Market in China Gains Favor of both Global and Local Players
    • Table 127: Chinese Human Albumin Products Market by Leading Players (2014): Percentage Breakdown of Volume Sales for Baxter Healthcare, China Biologic (CBPO), CNBG Shanghai Institute, CSL Behring, Grifols International, Octapharma, Shanghai RAAS, and Others (includes corresponding Graph/Chart)
    • Key Statistics
    • Table 128: Chinese IVIG (Intravenous Immunoglobulin) Products Market by Leading Players (2014): Percentage Breakdown of Volume Sales for China Biologic (CBPO), CNBG Shanghai Institute, Hualan Biological, Shanghai RAAS, and Others (includes corresponding Graph/Chart)
    • Table 129: Chinese Coagulation Factor VIII Products Market by Leading Players (2014): Percentage Breakdown of Volume Sales for China Biologic (CBPO), Greencross China, Hualan Biological, and Shanghai RAAS (includes corresponding Graph/Chart)
    • Table 130: Chinese Hepatitis B Ig Products Market by Leading Players (2014): Percentage Breakdown of Volume Sales for Anhui Tonrol, China Biologic (CBPO), CNBG Shanghai Institute, Hualan Biological, Hunan Nanyue, Shenzhen Weiwu, Sichuan Yuanda Shuyang, and Others (includes corresponding Graph/Chart)
    • Table 131: Chinese Rabies Ig Products Market by Leading Players (2014): Percentage Breakdown of Volume Sales for Anhui Tonrol, China Biologic (CBPO), CNBG Shanghai Institute, Guangdong Shuanglin Bio-Pharmacy, Hualan Biological, Hunan Nanyue, Sichuan Yuanda Shuyang Pharmaceutical, and Others (includes corresponding Graph/Chart)
    • Table 132: Chinese Tetanus Ig Products Market by Leading Players (2014): Percentage Breakdown of Volume Sales for Anhui Tonrol, China Biologic (CBPO), CNBG Shanghai Institute, Hualan Biological , Sichuan Yuanda Shuyang Pharmaceutical, and Others (includes corresponding Graph/Chart)
    • Table 133: Chinese Human PCC (Prothrombin Complex Concentrate) Market by Leading Players (2014): Percentage Breakdown of Volume Sales for Hualan Biological, and Others (includes corresponding Graph/Chart)
    • Table 134: Chinese Human Ig Market by Leading Players (2014): Percentage Breakdown of Volume Sales for China Biologic (CBPO), CNBG Shanghai Institute, Hualan Biological, and Sichuan Yuanda Shuyang Pharmaceutical (includes corresponding Graph/Chart)
    • Table 135: Chinese Human Fibrinogen Products Market by Leading Players (2014): Percentage Breakdown of Volume Sales for Hualan Biological, Jiangxi Boya Bio-Pharmaceutical, Shanghai RAAS, and Others (includes corresponding Graph/Chart)
    • Table 136: Chinese Plasma Collection Market by Leading Players (2014): Percentage Breakdown of Plasma Collection Volume for Anhui Tonglu, Chengdu Rongsheng Pharmaceutical, China Biologic (CBPO), Hualan Biological, Shanxi Kangbao Biological, Sichuan Yuanda Shuyang Pharmaceutical, and Others (includes corresponding Graph/Chart)
    • Table 137: Chinese Plasma Market by Leading Players (2014): Percentage Breakdown of Plasma Output Volume for China Biologic (CBPO), CNBG Shanghai Institute, Hualan Biological, Shanghai RAAS, and Others (includes corresponding Graph/Chart)
    • Table 138: Leading Companies in the Chinese Whole Blood Processing Market (2014): Percentage Breakdown of Volume Sales for Fresenius, Shanghai Kindly Enterprise Development Group, Terumo, WEGO and Others (includes corresponding Graph/Chart)
    • Strategic Corpoate Development
    • Select Key Players
  • B. Market Analytics
    • Table 139: Chinese Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 140: Chinese Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 141: Chinese 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

5b. REST OF ASIA-PACIFIC

  • A. Market Analysis
    • Current and Future Analysis
    • Overview of Select Regional Markets
      • Australia
      • National Blood Supply: An Overview
      • Role of National Blood Authority
      • Maintenance Expenditure on the Rise
      • India
      • Demand for Blood Banking Equipment Market on the Rise
      • Recent Trends in the Market
      • Indian Blood Banking Market Witnesses Major Transformations
      • Market Growth - Influencing Factors
      • Increased Awareness Drives Voluntary Blood Donations in India
      • Competitive Scenario
      • Indonesia
    • Strategic Corporate Developments
    • Bharat Serums and Vaccines Ltd. - A Leading Indian Player for Plasma Fractionation
  • B. Market Analytics
    • Table 142: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 143: Rest of Asia-Pacific Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 144: Rest of Asia-Pacific 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

6. LATIN AMERICA

  • A. Market Analysis
    • Current and Future Analysis
    • Table 145: Leading Companies in the Latin American Whole Blood Processing Market (2014): Percentage Breakdown of Volume Sales for Fresenius/Fenwal, Grifols, JP, Terumo and Others (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 146: Latin American Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Geographic Region - Brazil, and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 147: Latin American Historic Review for Blood Banking and Blood Products by Geographic Region - Brazil, and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 148: Latin American 14-Year Perspective for Blood Banking and Blood Products by Geographic Region - Percentage Breakdown of Value Sales for Brazil, and Rest of Latin America Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 149: Latin American Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 150: Latin American Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 151: Latin American 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

6a. BRAZIL

  • Market Analysis
    • Table 152: Brazilian Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 153: Brazilian Historic Review for Blood Banking and Blood Products by Product Group/ Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 154: Brazilian 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

6b. REST OF LATIN AMERICA

  • Market Analysis
    • Table 155: Rest of Latin America Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 156: Rest of Latin America Historic Review for Blood Banking and Blood Products by Product Group/ Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 157: Rest of Latin America 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

7. REST OF WORLD

  • A. Market Analysis
    • Current and Future Analysis
    • Omrix Biopharmaceuticals Ltd (Israel) - A Leading Plasma Fractionation Player
  • B. Market Analytics
    • Table 158: Rest of World Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 159: Rest of World Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 160: Rest of World 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

COMPETITIVE LANDSCAPE

Back to Top